Operating Lease, Right-of-Use Asset of Dyne Therapeutics, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Dyne Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • Dyne Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $20,742,000, a 16% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Dyne Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $20,742,000 -$3,873,000 -16% 31 Dec 2025 10-K 02 Mar 2026 2025 FY
Q3 2025 $21,818,000 -$3,803,000 -15% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $22,859,000 -$3,756,000 -14% 30 Jun 2025 10-Q 28 Jul 2025 2025 Q2
Q1 2025 $23,882,000 -$3,758,000 -14% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $24,615,000 -$3,997,000 -14% 31 Dec 2024 10-K 02 Mar 2026 2025 FY
Q3 2024 $25,621,000 -$3,970,000 -13% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $26,615,000 -$3,951,000 -13% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $27,640,000 -$3,898,000 -12% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $28,612,000 -$3,855,000 -12% 31 Dec 2023 10-K 27 Feb 2025 2024 FY
Q3 2023 $29,591,000 -$3,795,000 -11% 30 Sep 2023 10-Q 30 Oct 2023 2023 Q3
Q2 2023 $30,566,000 -$3,728,000 -11% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $31,538,000 -$3,842,000 -11% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $32,467,000 -$3,815,000 -11% 31 Dec 2022 10-K 05 Mar 2024 2023 FY
Q3 2022 $33,386,000 -$3,541,000 -9.6% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $34,294,000 +$33,918,000 +9021% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $35,380,000 +$34,818,000 +6195% 31 Mar 2022 10-Q 02 May 2022 2022 Q1
Q4 2021 $36,282,000 +$36,282,000 31 Dec 2021 10-K 02 Mar 2023 2022 FY
Q3 2021 $36,927,000 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $376,000 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 $562,000 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $0 31 Dec 2020 10-K 10 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.